Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elizabeth Barrett Insider Profile
4 Followers
Elizabeth Barrett, Director at SAGE Therapeutics, holds 3.00K shares in SAGE Therapeutics (Ticker: SAGE). Most recently, Elizabeth Barrett Bought $2,000 shares of SAGE Therapeutics on Aug 11, 2023 for an estimated value of 37.26K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-54.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Elizabeth Barrett's holdings
Insider Roles
Director
Roles that Elizabeth Barrett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Elizabeth Barrett
Elizabeth Barrett's Trading History
List of latest transactions for each holding click on a transaction to see Elizabeth Barrett's performance on stock
You May Also Like
Elizabeth Barrett insider profile FAQ
What is the percentage of profitable transactions made by Elizabeth Barrett?
The percentage of profitable transactions made by Elizabeth Barrett is 0%.
What is the average return per transaction made by Elizabeth Barrett?
The average return per transaction made by Elizabeth Barrett is -54.60%.
What stocks does Elizabeth Barrett hold?
Elizabeth Barrett holds: SAGE stocks.
What was Elizabeth Barrett’s latest transaction?
Elizabeth Barrett latest transaction was an Informative Buy of $37.26K.
What was Elizabeth Barrett's most profitable transaction?
Elizabeth Barrett’s most profitable transaction was an Informative Buy of SAGE stock on August 11, 2023. The return on the trade was -35.90%.
What is Elizabeth Barrett's role in SAGE Therapeutics?
Elizabeth Barrett's role in SAGE Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.